Piedmont Investment Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,074
Closed -$238K 1237
2019
Q1
$238K Buy
10,074
+443
+5% +$10.3K 0.01% 968
2018
Q4
$214K Buy
9,631
+285
+3% +$6.83K 0.01% 904
2018
Q3
$243K Buy
9,346
+517
+6% +$14.3K 0.01% 890
2018
Q2
$238K Buy
8,829
+47
+0.5% +$1.25K 0.01% 751
2018
Q1
$227K Buy
8,782
+280
+3% +$7.65K 0.01% 669
2017
Q4
$234K Sell
8,502
-647
-7% -$17.2K ﹤0.01% 655
2017
Q3
$205K Sell
9,149
-53
-0.6% -$1.2K ﹤0.01% 723
2017
Q2
$244K Buy
+9,202
New +$246K 0.01% 631

Other funds holding TBI

Piedmont Investment Advisors's TBI Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Trueblue (TBI) in Q2 2019, closing a stake of 10,074 shares — an estimated $238K sold.

Piedmont Investment Advisors first reported a position in TBI in Q2 2017 and held it in 8 quarters. The position peaked at $244K in Q2 2017. 185 funds tracked by Wall St. Rank hold TBI as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Trueblue position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 10,074 Trueblue shares in Q2 2019, an estimated $238K.
  • Piedmont Investment Advisors first reported a position in Trueblue in Q2 2017 and held it in 8 quarters.
  • Piedmont Investment Advisors's Trueblue position peaked at $244K in Q2 2017.
  • 185 funds tracked by Wall St. Rank held Trueblue as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.